Current IVF testing platforms only test for ~50% of causes of IVF
Current IVF testing platforms only test for ~50% of causes of IVF failure/pregnancy loss leading to most patients undergoing 2-3 cycles, leading to high financial and emotional costs for patients.
A genomic test which screens for all (1000+) known causes of IVF cycle failure/pregnancy loss
Juniper Genomics has developed a genomic test which screens for all (1000+) known causes of IVF cycle failure/pregnancy loss. Furthermore, Juniper seeks to develop a large genetic dataset which will allow for identification of all genetic causes of IVF failure, leading to increased chances of IVF success.
USD 36B market
By disrupting the incumbent legacy test and improving IVF treatment data, Juniper hopes to enter the ~$36B IVF market.
"AS [ a doctor], I want to provide the most comprehensive and accurate panel of tests available and Juniper is the only offering I have seen that has the potential to deliver on all of these fronts.”
Dr. Meera Shah, MD (Reproductive Endocrinology and Infertility Specialist at Nova IVF, Stanford)
Get in touch
Contact us for more information about how we can help you invest in healthcare, biotech, climate tech, or advanced systems.